Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review (Q38109663)

30 June 2019

title

Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review (English)

1 reference

30 June 2019

main subject

biomarker

0 references

traumatic brain injury

0 references

1 reference

Shoji Yokobori

1

1 reference

30 June 2019

Khadil Hosein

2

1 reference

30 June 2019

Stephen Burks

3

1 reference

30 June 2019

Ishna Sharma

4

1 reference

30 June 2019

Shyam Gajavelli

5

1 reference

30 June 2019

Ross Bullock

6

1 reference

30 June 2019

publication date

27 May 2013

1 reference

30 June 2019

CNS Neuroscience & Therapeutics

published in

1 reference

30 June 2019

volume

19

1 reference

30 June 2019

page(s)

556-565

1 reference

30 June 2019

issue

8

1 reference

30 June 2019

Tracking the silent epidemic and educating the public: CDC's traumatic brain injury-associated activities under the TBI Act of 1996 and the Children's Health Act of 2000.

cites work

1 reference

The public health approach to traumatic brain injury: an overview of CDC's research and programs

21 January 2018

1 reference

Neuroprotection in brain and spinal cord trauma

21 January 2018

1 reference

Multifunctional drugs for head injury

21 January 2018

1 reference

Surgical management of traumatic parenchymal lesions

21 January 2018

1 reference

Surgical management of posterior fossa mass lesions.

21 January 2018

1 reference

Surgical management of depressed cranial fractures.

21 January 2018

1 reference

Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss

21 January 2018

1 reference

Evolution of neurofilament subtype accumulation in axons following diffuse brain injury in the pig.

21 January 2018

1 reference

Axonal cytoskeletal changes after non-disruptive axonal injury.

21 January 2018

1 reference

Heavy neurofilament accumulation and alpha-spectrin degradation accompany cerebellar white matter functional deficits following forebrain fluid percussion injury.

21 January 2018

1 reference

Hyperphosphorylated neurofilament NF-H as a predictor of mortality after brain injury in children.

21 January 2018

1 reference

Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury.

21 January 2018

1 reference

Biological markers in CSF and blood for axonal degeneration in multiple sclerosis

21 January 2018

1 reference

Disruption of MAP-2 immunostaining in rat hippocampus after traumatic brain injury.

21 January 2018

1 reference

C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome.

21 January 2018

1 reference

Cerebrospinal fluid cleaved-tau protein and 9-hydroxyoctadecadienoic acid concentrations in pediatric patients with hydrocephalus

21 January 2018

1 reference

Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins.

21 January 2018

1 reference

A new in vitro model of the glial scar inhibits axon growth

21 January 2018

1 reference

Tau proteins in serum predict outcome after severe traumatic brain injury.

21 January 2018

1 reference

Serum cleaved tau does not predict postconcussion syndrome after mild traumatic brain injury

21 January 2018

1 reference

Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury.

21 January 2018

1 reference

Microtubule-associated proteins

21 January 2018

1 reference

Selective localization of messenger RNA for cytoskeletal protein MAP2 in dendrites

21 January 2018

1 reference

Novel differential neuroproteomics analysis of traumatic brain injury in rats.

21 January 2018

1 reference

Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation

21 January 2018

1 reference

Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury.

21 January 2018

1 reference

Extensive degradation of myelin basic protein isoforms by calpain following traumatic brain injury.

21 January 2018

1 reference

Proteolysis of multiple myelin basic protein isoforms after neurotrauma: characterization by mass spectrometry

21 January 2018

1 reference

Increased CSF concentrations of myelin basic protein after TBI in infants and children: absence of significant effect of therapeutic hypothermia

21 January 2018

1 reference

Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: a possible screening tool.

21 January 2018

1 reference

Serum biomarker concentrations and outcome after pediatric traumatic brain injury

21 January 2018

1 reference

Serum-myelin-basic-protein assay in diagnosis and prognosis of patients with head injury

21 January 2018

1 reference

Diffuse axonal injury: novel insights into detection and treatment

21 January 2018

1 reference

S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls.

21 January 2018

1 reference

Selective metabolic reduction in gray matter acutely following human traumatic brain injury

21 January 2018

1 reference

Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury.

21 January 2018

1 reference

Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cerebrospinal fluid

21 January 2018

1 reference

Serum biochemical markers for post-concussion syndrome in patients with mild traumatic brain injury

21 January 2018

1 reference

Multiple indicators model of long-term mortality in traumatic brain injury.

21 January 2018

1 reference

Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury.

21 January 2018

1 reference

The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury.

21 January 2018

1 reference

Neuron-specific enolase as an aid to outcome prediction in head injury.

21 January 2018

1 reference

Association of CSF biomarkers and secondary insults following severe traumatic brain injury

21 January 2018

1 reference

Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.

21 January 2018

1 reference

Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome.

21 January 2018

1 reference

Serum S-100B protein in severe head injury

21 January 2018

1 reference

S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury

21 January 2018

1 reference

GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.

21 January 2018

1 reference

Discordant temporal patterns of S100beta and cleaved tau protein elevation after head injury: a pilot study.

21 January 2018

1 reference

Correlation of computed tomography findings and serum brain damage markers following severe head injury.

21 January 2018

1 reference

Detection of traumatic brain injury with magnetic resonance imaging and S-100B protein in children, despite normal computed tomography of the brain.

21 January 2018

1 reference

Serum S100B protein in early management of patients after mild traumatic brain injury.

21 January 2018

1 reference

Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.

21 January 2018

1 reference

An acidic protein isolated from fibrous astrocytes

21 January 2018

1 reference

Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke.

21 January 2018

1 reference

Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.

21 January 2018

1 reference

Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma.

21 January 2018

1 reference

Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator

21 January 2018

1 reference

Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome.

21 January 2018

1 reference

Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study

21 January 2018

1 reference

Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury

21 January 2018

1 reference

Evidence for an interaction between ubiquitin-conjugating enzymes and the 26S proteasome

21 January 2018

1 reference

Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease

21 January 2018

1 reference

Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system

21 January 2018

1 reference

Proteasome inhibition arrests neurite outgrowth and causes "dying-back" degeneration in primary culture

21 January 2018

1 reference

Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation

21 January 2018

1 reference

Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention

21 January 2018

1 reference

Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids

21 January 2018

1 reference

Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI

21 January 2018

1 reference

Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury

21 January 2018

1 reference

The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury

21 January 2018

1 reference

Proteolysis of submembrane cytoskeletal proteins ankyrin-G and αII-spectrin following diffuse brain injury: a role in white matter vulnerability at Nodes of Ranvier

21 January 2018

1 reference

Dicyclomine, an M1 muscarinic antagonist, reduces biomarker levels, but not neuronal degeneration, in fluid percussion brain injury

21 January 2018

1 reference

Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.

21 January 2018

1 reference

A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels.

21 January 2018

1 reference

Cytoskeletal protein degradation and neurodegeneration evolves differently in males and females following experimental head injury

21 January 2018

1 reference

Neuroimmunophilin ligand V-10,367 is neuroprotective after 24-hour delayed administration in a mouse model of diffuse traumatic brain injury

21 January 2018

1 reference

The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury

21 January 2018

1 reference

Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats.

21 January 2018

1 reference

Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury

21 January 2018

1 reference

Biochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion

21 January 2018

1 reference

Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings.

21 January 2018

1 reference

The S100 protein family: history, function, and expression

21 January 2018

1 reference

αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients

21 January 2018

1 reference

Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.

21 January 2018

1 reference

alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury

21 January 2018

1 reference

Human traumatic brain injury alters plasma microRNA levels.

21 January 2018

1 reference

Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children.

21 January 2018

1 reference

Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury.

21 January 2018

1 reference

Simultaneous Degradation of αII- and βII-Spectrin by Caspase 3 (CPP32) in Apoptotic Cells

21 January 2018

1 reference

Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography

21 January 2018

1 reference

12 December 2020

Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation

1 reference

12 December 2020

Cytochrome c release and caspase activation in traumatic axonal injury

1 reference

12 December 2020

Temporal profile and cell subtype distribution of activated caspase-3 following experimental traumatic brain injury

1 reference

12 December 2020

Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury

1 reference

12 December 2020

Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein

1 reference

12 December 2020

Creatine kinase and its isozymes

1 reference

12 December 2020

Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children

1 reference

12 December 2020

Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children

1 reference

12 December 2020

Surgical management of acute epidural hematomas.

1 reference

12 December 2020

Surgical management of acute subdural hematomas.

1 reference

12 December 2020

Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury.

1 reference

12 December 2020

Guidelines for the management of severe traumatic brain injury.

1 reference

12 December 2020

Cerebrospinal s100-B: a potential marker for progressive intracranial hemorrhage in patients with severe traumatic brain injury.

1 reference

12 December 2020

Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury

1 reference

12 December 2020

Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.

1 reference

12 December 2020

Immunohistochemistry and serum values of S-100B, glial fibrillary acidic protein, and hyperphosphorylated neurofilaments in brain injuries.

1 reference

12 December 2020

Neurofilament protein phosphorylation--where, when and why

1 reference

12 December 2020

Creatine phosphokinase-MB (CPK-MB) and the diagnosis of myocardial infarction

1 reference

12 December 2020

The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis

1 reference

12 December 2020

Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury

1 reference

12 December 2020

Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results

1 reference

12 December 2020

Identifiers

DOI

10.1111/CNS.12127

1 reference

30 June 2019

PMCID

6493562

1 reference

30 June 2019

PubMed ID

23710877

1 reference

30 June 2019